tiprankstipranks
Trending News
More News >
Labixiaoxin Snacks Group Ltd. (HK:1262)
:1262
Hong Kong Market

Labixiaoxin Snacks Group Ltd. (1262) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Labixiaoxin Snacks Group Ltd.

(1262)

Rating:39Underperform
Price Target:
Labixiaoxin Snacks Group Ltd. is facing significant financial challenges, including high leverage and negative cash flow, which negatively impact its financial performance. Technical analysis indicates bearish momentum with potential oversold conditions. The valuation is concerning due to a negative P/E ratio and lack of dividend yield, suggesting limited investor returns. These factors contribute to a low overall stock score.

Labixiaoxin Snacks Group Ltd. (1262) vs. iShares MSCI Hong Kong ETF (EWH)

Labixiaoxin Snacks Group Ltd. Business Overview & Revenue Model

Company DescriptionLabixiaoxin Snacks Group Limited, an investment holding company, manufactures and sells jelly, confectionary, beverage, and other snack products in the People's Republic of China. It offers jelly snacks, such as fruit-flavored, canned fruit, yogurt, and mousse jellies; jelly beverages; lollipops, milk and gummy candies, and chocolates; fruit and vegetable beverages; and powdered milk tea, dried bean curd, and baked and beverage products under the Labixiaoxin, Sunshine City, Humor, and Xiangdoufang brands. The company was formerly known as China Lifestyle Food and Beverages Group Limited and changed its name to Labixiaoxin Snacks Group Limited in June 2012. The company was founded in 2000 and is headquartered in Jinjiang, the People's Republic of China. Labixiaoxin Snacks Group Limited is a subsidiary of Alliance Food and Beverages (Holding) Company Limited.
How the Company Makes MoneyLabixiaoxin Snacks Group Ltd. generates revenue primarily through the sale of its snack products. The company has established a broad distribution network that allows it to reach a wide array of retail outlets and consumers. Key revenue streams include direct sales to supermarkets, convenience stores, and other retail channels. Additionally, the company may earn income from any strategic partnerships or collaborations with other food and beverage companies, though specific details on such partnerships are not available. The company's growth and profitability are influenced by its ability to innovate in product development, maintain competitive pricing, and expand its market presence.

Labixiaoxin Snacks Group Ltd. Financial Statement Overview

Summary
Labixiaoxin Snacks Group Ltd. exhibits revenue growth but faces challenges in profitability and cash flow generation. High leverage and declining equity are key risks, while operational inefficiencies further pressure financial stability. Strategic improvements are necessary to enhance financial health.
Income Statement
45
Neutral
The company shows some revenue growth with a 13.39% increase from 2023 to 2024, but profitability is a concern given the negative net profit margin of -10.79% for 2024. The gross profit margin is 27.06%, indicating some cost control, but negative EBIT and EBITDA margins suggest operational inefficiencies.
Balance Sheet
40
Negative
The high debt-to-equity ratio of 2.13 in 2024 indicates significant leverage, posing financial stability risks. The equity ratio is 27.02%, showing moderate asset financing by equity, but a declining trend in stockholders' equity suggests weakened financial health.
Cash Flow
30
Negative
The absence of positive operating cash flow and free cash flow in 2024 is concerning, highlighting potential liquidity issues. Previous periods showed improvement in free cash flow, but the lack of data for 2024 prevents a comprehensive analysis.
Breakdown
Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
866.67M764.38M684.26M648.07M508.84M
Gross Profit
234.62M218.94M244.19M224.28M166.54M
EBIT
-73.26M-82.06M-17.72M37.97M-23.71M
EBITDA
-35.72M-46.04M658.00K81.80M108.73M
Net Income Common Stockholders
-93.46M-104.75M-75.33M-65.20M-29.40M
Balance SheetCash, Cash Equivalents and Short-Term Investments
52.50M44.32M71.88M80.57M258.84M
Total Assets
793.84M810.91M977.31M1.29B1.53B
Total Debt
456.40M451.27M512.44M565.59M690.74M
Net Debt
403.90M406.95M440.56M485.02M431.90M
Total Liabilities
579.32M588.35M650.00M887.41M1.06B
Stockholders Equity
214.52M222.56M327.31M402.64M467.84M
Cash FlowFree Cash Flow
0.0055.42M-4.98M-156.86M-21.57M
Operating Cash Flow
0.0088.64M15.46M-135.29M-12.47M
Investing Cash Flow
0.00-32.89M55.94M113.42M300.93M
Financing Cash Flow
0.00-83.31M-80.09M-156.41M-54.46M

Labixiaoxin Snacks Group Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.52
Price Trends
50DMA
1.49
Positive
100DMA
1.50
Positive
200DMA
1.63
Positive
Market Momentum
MACD
0.21
Negative
RSI
90.91
Negative
STOCH
93.06
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1262, the sentiment is Positive. The current price of 2.52 is above the 20-day moving average (MA) of 1.69, above the 50-day MA of 1.49, and above the 200-day MA of 1.63, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 90.91 is Negative, neither overbought nor oversold. The STOCH value of 93.06 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1262.

Labixiaoxin Snacks Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$8.81B14.924.67%6.17%3.60%-2.89%
39
Underperform
HK$550.41M-42.82%10.98%29.31%
$24.57B6.179.66%1.41%
$66.68B35.1527.96%2.50%
$135.18M-20.26%
54
Neutral
HK$982.71M13.492.75%3.57%-11.89%-69.45%
39
Underperform
HK$441.97M-69.34%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1262
Labixiaoxin Snacks Group Ltd.
2.52
1.37
119.13%
CRBJF
China Resources Land
3.08
-0.17
-5.23%
HKXCF
Hong Kong Exchanges & Clearing
50.53
18.91
59.80%
NBBTF
Natural Beauty Bio-Technology
0.06
0.02
50.00%
HK:0609
Tiande Chemical Holdings Limited
1.12
0.07
6.67%
HK:0727
Crown International Corporation Limited
1.39
-0.69
-33.17%

Labixiaoxin Snacks Group Ltd. Corporate Events

Labixiaoxin Snacks Group Ltd. Announces 2025 Annual General Meeting
Apr 28, 2025

Labixiaoxin Snacks Group Ltd. has announced its upcoming annual general meeting scheduled for June 19, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, re-election of directors, and authorization for the board to fix remuneration for directors and auditors. The meeting will also consider resolutions to empower directors to manage share-related activities, which could impact the company’s capital structure and shareholder value.

Labixiaoxin Snacks Reports Revenue Growth Amid Continued Losses in 2024
Mar 28, 2025

Labixiaoxin Snacks Group Ltd. reported its annual financial results for the year ending December 31, 2024, showing a 13.4% increase in revenue to RMB 866.7 million. Despite the revenue growth, the company faced a net loss of RMB 93.5 million, a decrease from the previous year’s loss. The gross profit margin slightly declined to 27.1%, and the return on equity worsened to -41.7%. These results indicate ongoing financial challenges and may impact the company’s market positioning and stakeholder confidence.

Labixiaoxin Snacks Group Schedules Board Meeting for Annual Results and Dividend Decision
Mar 17, 2025

Labixiaoxin Snacks Group Ltd. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend payment, which could impact shareholder returns and reflect the company’s financial health.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.